Articles from Jack Nathan Medical Corp.

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health” or the “Company”) is pleased to announce the appointment of Mr. Bharat Choudhary as the Company’s new permanent Chief Financial Officer (CFO).

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) announced today its unaudited financial results for the first quarter of fiscal 2022, which ended April 30, 2021. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).

Jack Nathan Medical Corp. (TSXV: JNH) (OTCQB: JNHMF) (“Jack Nathan Health” “JNH” or the “Company”) announced today that Michael A. Pangia, a seasoned industry veteran with over 25 years of executive leadership experience in the financial and technology sector, has been retained by the Company to serve as a strategic advisor.

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) announced today its audited financial results for the fourth quarter and fiscal year-ended January 31, 2021. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”).

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health" or the "Company") announces that following a strategic review of the Company, the Board of Directors of the Company (the "Board") has terminated the employment of Mr. George Barakat as Chief Executive Officer of the Company and its subsidiaries. Mr. Barakat will continue to serve as a director of the Company. Mr. Neil J. Labatte has been appointed as Chairman of the Board of Directors. Mike Marchelletta, Co-founder and President will assume the role of Interim Chief Executive Officer, effective immediately. The Company is commencing a search process to identify a suitable successor to fill the role of Chief Executive Officer on a permanent basis.

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health” “JNH'' or the “Company”) is pleased to announce that it has been approved for graduation to Tier 1 Issuer status from Tier 2 Issuer status by the TSX Venture Exchange (the "TSXV"), effective May 19, 2021.

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health” “JNH” or the “Company”), a provider of primary care medical clinics located in Walmart® Supercentres under the Jack Nathan Health® brand announced three new locations in Western Canada, with two locations opening in Alberta and one in British Columbia.

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health” “JNH” or the “Company”), announced its subsidiary JNH Medico Mexico S.A. DE C.V, a provider of primary care medical clinics located in Walmart Supercentres ® and other Walmart Mexico formats under the Jack Nathan Health ® brands, has signed an addendum to its ongoing Master Service Agreement (“MSA”) which now gives Jack Nathan Health an additional 153 new locations for medical clinic expansion, throughout the country, bringing the Company’s total number of future clinics there to 203, all corporately owned and operated.

Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health” “JNH'' or the “Company”) announced that its wholly-owned subsidiary, Writi Inc. (“Writi”), has secured the software installation for 15 new Long-Term Care (LTC) homes, representing over 1650 beds. This integration, when complete, will double the number of LTCs using the Writi platform and increase its recurring revenue install base to a total of 30 LTCs and over 3200 beds in Ontario.